Search results
Dr. Reddy’s Laboratories, a leading multinational pharmaceutical company based in India and overseas, committed to providing affordable and innovative medicines for healthier lives. We use cookies to gain insight on how you use this website and make improvements to based on your interaction with the pages. By clicking “Accept all” you agree to the use of all cookies and the corresponding data processing.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas.
Dr Reddys Labs Share Price: Get the latest updates on the performance, valuation, earnings, forecasts and recommendations of Dr Reddys Laboratories Ltd., one of the leading pharmaceutical ...
Dr. Reddy’s Laboratories commenced its generics business in India in 1986 and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. Portfolio spanning wide range of therapy and disease areas.
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. ...
6 days ago · Dr. Reddy's Laboratories Limited Share Price Today, Live NSE Stock Price: Get the latest Dr. Reddy's Laboratories Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account, research, results and more details at NSE India.
3 days ago · Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Dr. Reddy's Laboratories, including: Last traded price 6580.0, Market capitalization: 110708.19, Volume: 459, Price-to-earnings ratio 19.85, Earnings per share 334.35.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian ...
6 days ago · Hyderabad-based Dr. Reddy’s Laboratories has announced the signing of a non-exclusive patent licensing agreement with Japanese drug maker Takeda Pharmaceutical Company. This collaboration aims to introduce Vonoprazan tablets, a novel treatment for gastrointestinal disorders, to patients across India. Vonoprazan tablets, orally active potassium competitive acid blockers (PCAB), are used to treat reflux esophagitis and other acid peptic disorders. ...
Dr. Reddy’s maintains a work environment, free from discrimination, and is an equal opportunity employer. The company is committed to equal employment opportuninty and employs all qualified persons without regard to race, colour, religion, national origin, sex, age, disability status, genetics, sexual orientation, gender identity or expression, marital status, citizenship or any other characteristic or classification protected by the applicable law(s) of the countries we operate in. ...
